[3P] Poster Presentation 3

[3P-891] Comparison of ADCC activity between daratumumab and isatuximab in multiple myeloma with varying CD38 expression levels

○Yuto Takahashi¹, akihiro Kitadate², Sayaka Iwama¹, Wataru Kuroki², Sho Ikeda², Naoto Takahashi² (1. Dept. of Life Sci., Grad. Sch. of Eng. Sci., Univ. of Akita, 2. Dept. of Hematology, Nephrology, and Rheumatology, Grad. Sch. of Med., Univ. of Akita)